Topic Summary
Results from the SURMOUNT-MAINTAIN trial examine how tirzepatide dose reduction affects long-term weight and cardiometabolic outcomes, offering GPs practical guidance on when and how to consider down-titration for patients.
This activity is designed to provide convenient up-to-date information, latest research, and practical information to enhance and further the education of medical professionals working within general practice.
Featured Expert
Dr Paige Lanyon-Roberts
General Practitioner, Bariatric Doctor and Surgical Assistant; Medical Director, MedSurg Weight Loss
Learning Objectives
- Update management guidelines with recommendations to changes for daily clinical practices
- Discuss new concepts, assessments, and management of common clinical issues and how these will impact clinical practice
- Create improved management strategies, and safety systems in treatment plans
- Evaluate the relative merits of treatment options and diagnostic tests to ensure better patient care and safety
CPD and Accreditation
This activity is accredited with the RACGP and ACRRM for the following hours:
- 0.5 hours in the Educational Activities (EA)
- 0.5 hours Reviewing Performance (RP)
- 1 hour Measuring Outcomes (MO)
You can track your Healthed learning and download a CPD Statement as evidence of completion, which may support self‑claimed professional development with your professional body.
Disclosure Statement
Proudly supported by an independent educational grant from Lilly. June 2026
